plasma viscosity, prothrombotic screen and protein electrophoresis were normal. Free protein S was 56% (normal values 23-63%), protein C activity 87% (normal values 70-130%), anti-thrombin 92% (normal values 75-125%) and activated protein C resistance 3.6 (normal values 2.6-3.8). No factor V Leiden test was performed as the screening test (activated protein C resistance) was negative. Her alcohol intake of 30 units per week resulted in a mild thrombocytopenia (121 X 10 9 /1) and a raised gamma-glutamyl transpeptidase (419). Her vision at present is counting fingers in the right eye and 6/18 in the left eye.
Comment
Activated protein C resistance has been described as the most common known cause of CRVO in young patients under 50 years of age. 
Case re p ort
A 47-year-old woman with known Waardenburg's syndrome was found on routine ocular examination to have an intraocular mass in her left eye. Her visual acuity was 6/6 in both eyes. She showed several of the classic features of Waardenburg's syndrome, including white forelock, mild telecanthus and unilateral congenital deafness. Her father and son were similarly affected. Ocular features included iris heterochromia, the left iris being a uniform blue colour ( Fig. 1 ) and the right iris brown in colour apart from the superior third which was blue (Fig. 2) . Both fundi showed diffuse retinal pigment epithelial (RPE) loss with areas of pigment clumping (Fig. 3) .
The pertinent finding was in the inferior quadrant of the left eye where a 9 X 7 X 2.5 mm ill-defined pink retinal mass with surrounding subretinal exudation and overlying serous retinal detachment was found (Fig. 4 ). There were attenuated feeder vessels, but no dilated, tortuous feeder vessels as seen with the retinal capillary haemangioma associated with Von Hippel's disease. As the patient was asymptomatic, cautious observation was advised. the patient to the development of this mass, similar to those eyes with retinitis pigmentosa. Waardenburg's syndrome should be added to the list of conditions associated with vasoproliferative tumours of the ocular fundus.
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